iPS Bio, Inc.
PrivateLast Round
Series A
May 17, 2021
Est. Valuation
$21.4M
Total Funding Raised
$7.13M
Company Overview
iPS Bio, Inc. operates in Healthcare & Life Sciences and is based in Seongnam-si. Its latest recorded funding round was a Series A round in May 2021.
iPS Bio, Inc. is a biotechnology company that develops induced pluripotent stem cell (iPSC)-based cell therapies and drug discovery platforms for neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iPS Bio, Inc. Comparables
Compare iPS Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Orizuru Therapeutics, Inc. | 76% | |
| Aspen Neuroscience | 70% | |
| Bayer AG | 70% |
For institutional investors. Book with your work email.
iPS Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 17, 2021 | ||||
| Grant | Jun 1, 2020 |
For institutional investors. Book with your work email.
iPS Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TIPS (Tech Incubator Program for Startup) | Grant |
| Schmidt | Seed |
| Kolon Investment | Series A |
| LSK Investment | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2021
$7.1M round led by Kolon Investment and LSK Investment.
- Jun 1, 2020
Received grant from TIPS (Tech Incubator Program for Startup).
For institutional investors. Book with your work email.
iPS Bio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about iPS Bio, Inc.'s valuation, stock price, and market status.
Is iPS Bio, Inc. a public or private company?
iPS Bio, Inc. is a private company.
What is the current stock price of iPS Bio, Inc.?
iPS Bio, Inc. is a private company, so its shares have no public market price. Caplight tracks iPS Bio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is iPS Bio, Inc. worth (valuation)?
iPS Bio, Inc.'s valuation is estimated at $21.4M based on funding round data.
Can I buy iPS Bio, Inc. stock?
iPS Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was iPS Bio, Inc.'s last funding round?
iPS Bio, Inc.'s most recent funding round was Series A on May 17, 2021.
Who are the main investors in iPS Bio, Inc.?
Key investors in iPS Bio, Inc. include TIPS (Tech Incubator Program for Startup), Schmidt, Kolon Investment, LSK Investment.
Will iPS Bio, Inc. IPO soon?
No public IPO plans have been announced for iPS Bio, Inc..
How can I track iPS Bio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in iPS Bio, Inc.'s shares on secondary markets.